J&J Innovative Medicine

Johnson & Johnson Innovative Medicine is the medicines and therapies business of Johnson & Johnson, focused on advancing healthcare through rigorous science and patient-centered innovation. Its researchers work to develop new treatments, bringing discoveries from the laboratory toward care while championing patients throughout the process. The company’s core areas of focus are oncology, immunology, neuroscience and cardiopulmonary medicine, where it aims to address significant health needs and improve outcomes.

The organization provides information about its medicines, clinical trials and development pipeline, alongside resources for patients and caregivers. Healthcare professionals can explore product information, a clinical trial finder and details about the pre-approval process. Patients can learn about clinical trials, patient resources and access pathways. Johnson & Johnson Innovative Medicine also highlights its work in precision medicine, data science and digital health, as well as discovery, product development and supply. Through partnerships and innovation opportunities, it engages with external collaborators. Its website shares company news, research updates and information for prescribers, patients, investors, policymakers and media, supporting a broad community interested in medical innovation and the development of new treatments.